These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23129219)

  • 21. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Roles of Pin1 in Cancer Development and Progression.
    Han HJ; Choi BY; Surh YJ
    Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
    Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.
    Xu M; Cheung CC; Chow C; Lun SW; Cheung ST; Lo KW
    PLoS One; 2016; 11(6):e0156833. PubMed ID: 27258148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.
    Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T
    J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
    Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2006 Sep; 16(3):505-11. PubMed ID: 16865250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1].
    Lavoie SB; Albert AL; Vincent M
    Med Sci (Paris); 2003 Dec; 19(12):1251-8. PubMed ID: 14691750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.
    Leung KW; Tsai CH; Hsiao M; Tseng CJ; Ger LP; Lee KH; Lu PJ
    Oncol Rep; 2009 Apr; 21(4):1097-104. PubMed ID: 19288014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
    Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
    Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prolyl isomerase Pin1 in breast development and cancer.
    Wulf G; Ryo A; Liou YC; Lu KP
    Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling.
    Zhu Z; Zhang H; Lang F; Liu G; Gao D; Li B; Liu Y
    Clin Transl Oncol; 2016 Aug; 18(8):792-7. PubMed ID: 26497355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
    J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.
    Liou YC; Ryo A; Huang HK; Lu PJ; Bronson R; Fujimori F; Uchida T; Hunter T; Lu KP
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1335-40. PubMed ID: 11805292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.
    Wulf GM; Liou YC; Ryo A; Lee SW; Lu KP
    J Biol Chem; 2002 Dec; 277(50):47976-9. PubMed ID: 12388558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.